Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 13. Synthesis and Profiling of a Novel Amminium Prodrug of the HIV-1 Attachment Inhibitor BMS-585248
Alicia Regueiro‐Ren(Bristol-Myers Squibb (United States)), John F. Kadow(Bristol-Myers Squibb (United States)), Sandhya Rahematpura(Bristol-Myers Squibb (United States)), Nicholas A. Meanwell(Mario Negri Institute for Pharmacological Research), Jean Simmermacher-Mayer(Bristol-Myers Squibb (United States)), Xiaohua Huang(City Of Hope National Medical Center), Dawn D. Parker, Michael Sinz(Rutgers, The State University of New Jersey), Ming Zheng(Chinese Academy of Agricultural Sciences), Susan Jenkins(Bristol-Myers Squibb (Germany)), Kim A. Johnson(Circle (United States))
Cited by 9
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Highly Active and Selective Catalysts for the Formation of α-Aryl Ketones
|Journal of the American Chemical Society|2000|517
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Applications of fluorine-containing amino acids for drug design
|European Journal of Medicinal Chemistry|2019|238